Valeant Pharmaceuticals Intl Inc (NYSE:VRX)’s Ex-CEO Michael Pearson has been accused of unheeding the possibility of corruption in its option-purchase agreement with Philidor Rx Services LLC by the star witness from the side of government, Laizer Kornwasser. The former official of Valeant testified during a cross-examination that Pearson was...
Merck & Co., Inc. (NYSE:MRK) and US biotech startup Moderna Therapeutics have moved their 2016 partnership a step further by agreeing to share antigen mRNA cancer vaccines including mRNA-5671. Under the initial partnership, the two companies agreed to jointly develop and commercialize novel personalized messenger RNA (mRNA) cancer vaccines. Moderna...
Anthem Inc (NYSE:ANTM) is a leading health insurance company that has been competing at all levels with the leading health insurers of the country. But it seems it is not at all interested in the current high-power deals that are making a wave in the United States’ health insurance...
AbbVie Inc (NYSE:ABBV) has announced that it has signed an agreement with Samsung Bioepis plus its joint venture Biogen Inc (NASDAQ:BIIB) that will help reduce competition for their biosimilar version so as to boost Humira until 2023. This is the second agreement that the company has signed over the years...
Incyte Corporation (NASDAQ:INCY) shares went down rapidly after the company declared that its melanoma drug trial has failed. The company conducted the Phase 3 trial to establish the effectiveness of its drug epacadostat in combination with KEYTRUDA from Merck & Co., Inc.’s (NYSE:MRK) for treating patients suffering from metastatic or...
Cancer immunotherapy has a promising future despite suffering a major setback last Friday. Incyte Corporation (NASDAQ:INCY) announced that its trial drug epacadostat had failed to help melanoma patients, and the company is calling off the trial altogether. Epacadostatwas meant to work together with Keytruda, Merck & Co., Inc. (NYSE:MRK)'s blockbuster...
Ionis Pharmaceuticals Inc (NASDAQ:IONS) and Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY) have for many years focused on the development of the rare-disease drug. But Thursday turned out to be a low moment for the two. That was after Pfizer Inc (NYSE:PFE), a component of Dow Jones unleashed strong late-stage results for the...
Novavax Inc (NASDAQ:NVAX) reported the promotion of Mr. John J. Trizzino to SVP, Chief Financial Officer (CFO) and Chief Business Officer (CBO). Trizzino has been working as SVP, Commercial Operations, since 2014. As Chief Business Officer, he is now accountable for all commercial and pre-commercial launch execution and strategy...
Proteostasis Therapeutics Inc (NASDAQ:PTI) went up 22% in premarket trade on Thursday after the therapeutic company reported a less-than-expected loss for the fourth-quarter. The company further announced that the Food and Drug Administration had granted its cystic fibrosis drug orphan drug designation. The Orphan drug designation grants the company seven...
Prostate cancer is a health issue we can no longer avoid. It comes as a shocker to anyone when they discover that they have cancer.  However, a landmark study of the 4Kscore® test carried out by Opko Health Inc. (NASDAQ:OPK) seems to have something better to offer.  The 4Kscore...

Subscribe to our mailing list

* indicates required

Create a future where the human body can repair, restore, and rejuvenate itself

 

Trading Symbol

OTC: MJMD

The Next Big Global Cannabis Play